As European business winds down for the traditional August break, the Spanish pharmaceutical industry association, Farmaindustria, and the Spanish Health Ministry were still in negotiations regarding the limits on pharmaceutical spending over the next two years (Marketletters passim).
The latest proposals of both the Health Ministry and Farmaindustria are outlined below. As previously reported, Farmaindustria wants to include hospital debt for drug supplies in the negotiations, along with pricing freedom for non-reimbursable pharmaceutical products.
As the Marketletter went to press, no further information on the negotiations was available. It would appear that the two sides will have to pick up their talks after the summer break.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze